Task: Answer the multiple-choice question.
Query: Which drug exhibits a -0.718\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any other words.
Options:
a. Cc1c(C)n(C(=O)CSc2nncn2C)c2ccccc12
b. COc1cc2c(cc1NC(=O)c1cccc(Br)c1)CCCC2
c. COc1ccc(C(=O)n2nnc3ccccc32)cc1OC
d. Cc1cc([N+](=O)[O-])ccc1NC1CCCC1
Answer: b. COc1cc2c(cc1NC(=O)c1cccc(Br)c1)CCCC2
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COc1cc2c(cc1NC(=O)c1cccc(Br)c1)CCCC2
COc1cc2c(cc1NC(=O)c1cccc(Br)c1)CCCC2
3-bromo-N-(3-methoxy-5,6,7,8-tetrahydronaphthalen-2-yl)benzamide